MUSTANG BIO, INC. Quarterly Debt-to-equity in % from Q2 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Mustang Bio, Inc. quarterly Debt-to-equity history and growth rate from Q2 2017 to Q3 2024.
  • Mustang Bio, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -320 %, a 347% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -320 -450 -347% Sep 30, 2024
Q2 2024 -772 -869 -894% Jun 30, 2024
Q1 2024 535 +457 +583% Mar 31, 2024
Q4 2023 196 +137 +234% Dec 31, 2023
Q3 2023 130 +91.5 +238% Sep 30, 2023
Q2 2023 97.2 +71.9 +284% Jun 30, 2023
Q1 2023 78.4 +62.7 +401% Mar 31, 2023
Q4 2022 58.7 +50.4 +605% Dec 31, 2022
Q3 2022 38.4 +30.1 +363% Sep 30, 2022
Q2 2022 25.3 +16.8 +197% Jun 30, 2022
Q1 2022 15.7 +1.05 +7.19% Mar 31, 2022
Q4 2021 8.33 -15.6 -65.1% Dec 31, 2021
Q3 2021 8.3 -24.4 -74.6% Sep 30, 2021
Q2 2021 8.52 -31.2 -78.6% Jun 30, 2021
Q1 2021 14.6 -23.1 -61.2% Mar 31, 2021
Q4 2020 23.9 -16.5 -40.8% Dec 31, 2020
Q3 2020 32.7 -3.02 -8.46% Sep 30, 2020
Q2 2020 39.7 +9.9 +33.2% Jun 30, 2020
Q1 2020 37.7 +14.8 +64.5% Mar 31, 2020
Q4 2019 40.4 +29.5 +273% Dec 31, 2019
Q3 2019 35.7 +27.3 +328% Sep 30, 2019
Q2 2019 29.8 +22.9 +333% Jun 30, 2019
Q1 2019 22.9 +16.2 +243% Mar 31, 2019
Q4 2018 10.8 +6.33 +141% Dec 31, 2018
Q3 2018 8.35 +3.37 +67.7% Sep 30, 2018
Q2 2018 6.88 -2.83 -29.1% Jun 30, 2018
Q1 2018 6.67 Mar 31, 2018
Q4 2017 4.48 Dec 31, 2017
Q3 2017 4.98 Sep 30, 2017
Q2 2017 9.71 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.